The 28 tumours with BRAF mutations were enriched in CTCF binding site mutations (FDR = 5.8 × 10− 5, FC = 1.10), while 32 BRAF-wildtype tumours showed no enrichment (FDR = 0.31, FC = 1.03). This evidence concerns the gene BRAF and neoplasm.